Our Products

Product details Products Home
AfixAfixAfixAfixAfixAfix

Afix

Cefixime

Afix (Cefixime) is a broad spectrum cephalosporin antibiotic of 3rd generation for oral administration. It is a bactericidal antibiotic and is stable to hydrolysis by many beta-lactamases. Cefixime kills bacteria by interfering the synthesis of the bacterial cell wall. Cefixime is highly active against Neisseria gonorrhoeae, Haemophilus influenzae, Morexella catarrhalis including beta-lactamase producers, most of the Enterobacteriaceae, beta-haemolytic Streptococci (Group A & B) and Streptococcus pneumoniae. Cefixime is more active than other oral cephalosporins against Escherichia coli, Klebsiella spp, Proteus mirabilis and Serratia marcescens. Cefixime is also active against Streptococcus pyogenes. 40-50% of an oral dose is absorbed from gastro-intestinal tract, whether taken with meals or not. The plasma half life is usually about 3 to 4 hours and may be prolonged when there is renal impairment. About 65% is bound to plasma protein. Cefixime is mainly excreted unchanged in bile and urine.

Product Details

Presentation

Afix Capsule: Each capsule contains Cefixime BP equivalent to anhydrous Cefixime 200 mg.
Afix-400 Capsule: Each capsule contains Cefixime BP equivalent to anhydrous Cefixime 400 mg.
Afix-200 Tablet: Each tablet contains Cefixime BP equivalent to anhydrous Cefixime 400 mg.
Afix-400 Tablet: Each tablet contains Cefixime BP equivalent to anhydrous Cefixime 400 mg.
Afix Powder for Suspension: After preparation, each 5 ml reconstituted suspension contains Cefixime trihydrate BP equivalent to anhydrous Cefixime 100 mg.
Afix DS Powder for Suspension: After preparation, each 5 ml reconstituted suspension contains Cefixime trihydrate BP equivalent to anhydrous Cefixime 200 mg.

Pharmacology

Afix (Cefixime) is a broad spectrum cephalosporin antibiotic of 3rd generation for oral administration. It is a bactericidal antibiotic and is stable to hydrolysis by many beta-lactamases. Cefixime kills bacteria by interfering the synthesis of the bacterial cell wall. Cefixime is highly active against Neisseria gonorrhoeae, Haemophilus influenzae, Morexella catarrhalis including beta-lactamase producers, most of the Enterobacteriaceae, beta-haemolytic Streptococci (Group A & B) and Streptococcus pneumoniae. Cefixime is more active than other oral cephalosporins against Escherichia coli, Klebsiella spp, Proteus mirabilis and Serratia marcescens. Cefixime is also active against Streptococcus pyogenes. 40-50% of an oral dose is absorbed from gastro-intestinal tract, whether taken with meals or not. The plasma half life is usually about 3 to 4 hours and may be prolonged when there is renal impairment. About 65% is bound to plasma protein. Cefixime is mainly excreted unchanged in bile and urine.

Indication

Afix is indicated for the treatment of the following acute infections caused by susceptible microorganisms:
1. Upper respiratory tract infections: Otitis media and other URTI where the causative organism is known or suspected to be resistant to other commonly used antibiotics.
2. Lower respiratory tract infection: Bronchitis.
3. Urinary tract infections: Cystitis, cystourethritis, pyelonephritis, typhoid fever & gonococcal urethritis.
4. Gonorrhea (Uncomplicated)
5. Typhoid fever

Dosage & Administration

The usual course of treatment is 7 days. This may be continued for up to 14 days if required.

Afix Tablet & Capsule: Adult & Child over 10 years: 200-400 mg daily 1-2 divided doses.
Gonorrhea: 400 mg as a single dose.
Afix Powder for Suspension & DS Powder for Suspension:
Children above 6 months: 8 mg/kg daily in 1-2 divided doses or
6 months-1year: 75 mg daily
1-4 years: 100 mg daily
5-10 years: 200 mg daily
Typhoid fever: 20 mg/kg body weight daily in two divided dose for 8 days.

Contraindications

Patients with known hypersensitivity to cephalosporin antibiotics, children under 6 months.

Warning & Precautions

Cephalosporins should be given with caution to penicillin-sensitive patients, as there is some evidence of partial cross-allergenicity between the penicillins and cephalosporines. Cefixime should be administered with caution in patients with markedly impaired renal function. In patients whose creatinine clearance is less than 20 ml/min, it is recommended that a dose of 200 mg once daily should not be exceeded.

Side effects

Afix is generally well tolerated. The majority of adverse reactions observed in clinical trials was mild and self-limiting in nature. Gastro-intestinal disturbances: Diarrhoea (if severe diarrhoea occurs, Afix should be discontinued), changes in the color of stool, nausea, abdominal pain, dyspepsia, vomiting, flatulence have been reported. Central nervous system disturbances: Headache, dizziness, etc. Others: Hypersensitivity reactions which usually subsided upon discontinuation of therapy; infrequent and reversible haematological changes; elevation of serum amylase, etc.

Drug interaction

Carbamazepine: Elevated carbamazepine levels have been reported.
Warfarin and Anticoagulants: Increased prothrombin time with oe without clinical bleeding has been reported when cefixime is administered concomitantly.

Use in special groups

Use in Pregnancy: Pregnancy category B. There are no adequate and well-controlled studies in pregnant women. So this drug should be used during pregnancy only if clearly needed.
Use in Lactation: It is not known whether cefixime is excreted in human milk. So it is probably best either to avoid using the drug by the nursing mother or to discontinue breast feeding.
Use in Children: Safety and effectiveness of cefixime in children aged less than 6 months have not been established.

Packing

Afix Capsule: Box containing 12's capsules in Alu-Alu blister pack.
Afix-400 Capsule: Box containing 4's capsules in alu-alu blister pack.
Afix-200 Tablet: Box containing 10's tablets in alu-alu blister pack.
Afix-400 Tablet: Box containing 6's tablets in alu-alu blister pack.
Afix Powder for Suspension: Bottle containing dry powder for preparation of 30 ml/50 ml suspension.
Afix-DS Powder for Suspension: Bottle containing dry powder for preparation of 30 ml/50 ml suspension.

Other Products from
Antibiotic
 
Erythromycin
Erythromycin
Cefixime
Ciprofloxacin
Chloramphenicol
Meropenem
Cefuroxime
Cefuroxime + Clavulanic Acid
Ceftriaxone
Azithromycin
Azithromycin
Besifloxacin Hydrochloride
Ceftazidime
Clindamycin
Cefradine
Cefepime
Rifaximin
Lomefloxacin
Lemefloxacin
Amikacin Sulfate
Sparfloxacin
Moxifloxacin
Moxifloxacin
Moxifloxacin (enriched with Xanthan Gum)
Gentamicin
Levofloxacin
Tobramycin
Gatifloxacin
Cefpodoxime
Ofloxacin

© 2017. Aristopharma Ltd. All rights reserved.
Site by DIGITA iNTERACTIVE

HOME | PRODUCTS | FACILITIES | GLOBAL PRESENCE | NEWS | ABOUT US | CONTACT | CAREER

Webmail
Bookmark and Share